North America · US business day · Healthtech procurement trust asset · Demo template

US healthtech HIPAA + AI procurement evidence source map.

For healthtech SaaS, digital-health, patient-engagement, RCM, prior-authorization and AI workflow teams that are asked for HIPAA/PHI, BAA, SOC 2, HITRUST, AI data-use, human-review and cloud-cost evidence before procurement will move.

Request source-map fit checkDownload synthetic CSVSee evidence-room template

Region selected

North America / US business day. This run targets US healthcare and healthtech buyers who search during East Coast and Central business hours for procurement-safe AI, cloud trust and FinOps evidence.

Buyer pain-language

HIPAA AI vendor risk questionnairePHI AI data use evidenceBAA subprocessor registerhealthcare SaaS cloud cost allocationSOC 2 HITRUST evidence roomAI human review clinical boundarypatient engagement AI procurementLLM cost governance healthcare

Top competitors buyers already know

CloudZero, IBM Apptio Cloudability, VMware/CloudHealth, Vantage, Datadog Cloud Cost Management, AWS Cost Explorer, Azure Cost Management, Vanta, Drata, Secureframe, HITRUST, OneTrust, TrustArc, Conveyor, SafeBase and Whistic appear in adjacent FinOps, GRC, trust-center and questionnaire consideration sets.

What AICS must publish/build to enter top-3/top-5 consideration

Proof-before-platform assets

  • Evidence source maps that show how answers are controlled before sales or procurement sends them.
  • Demo owner dashboards connecting cloud/AI cost, PHI/data-boundary questions and human-review queues.
  • Comparison pages that position AICS around existing FinOps/GRC platforms rather than pretending to replace them.
  • Clearly labelled synthetic samples until real buyer-approved case studies exist.

Trust posture buyers can verify

  • Explicit no-fake-proof policy: no invented clients, logos, certificates, savings or compliance results.
  • Source links to public frameworks and buyer evidence themes: ONC privacy/security guidance, FinOps Foundation capabilities, HITRUST risk-management language and procurement questionnaire patterns.
  • CSV/downloadable artifacts that procurement, security, finance and product owners can inspect without contacting sales.

Source-map template

All rows are synthetic field examples only. They are not production data, not patient data, not PHI, not customer data, not a real healthtech case study and not procurement-win evidence.

Question areaBuyer languageSource to prepareEvidence ownerAdviser questionUnsafe claim to block
HIPAA and PHI boundaryDoes your AI workflow process PHI, ePHI or patient data?Data-flow diagram, field inventory, PHI/ePHI handling note, retention note.Privacy + productDoes counsel/privacy officer approve the stated HIPAA scope?“HIPAA compliant AI” without scoped evidence.
BAA and subprocessorsCan you sign a BAA and list AI/cloud subprocessors?BAA status tracker, subprocessor register, vendor/model register.Legal + vendor ownerWhich vendors require contractual review?“All vendors are automatically covered.”
SOC 2 / HITRUST evidenceDo you have SOC 2, HITRUST or security controls evidence?Control evidence index, current reports if available, policy owner, expiry date.Security + complianceWhat can be shared externally under NDA?Certification claims without a current report/certificate.
AI data useDo you use patient/customer data to train models?AI data-use policy, provider terms, prompt logging note, exception register.AI product + privacyIs training-use language approved for each workflow?“We never use data for training” without a source map.
Cloud and AI cost allocationCan costs be mapped by product, tenant, workflow or customer?Billing exports, tag policy, LLM API exports, owner mapping.Finance + engineeringWhat unit metric is safe to show buyers or board?Guaranteed cloud savings, ROI or runway claims.
Human reviewHow do you prevent AI from giving clinical, diagnosis, treatment, billing or coverage advice?Human-review rule, escalation runbook, prohibited-output list, QA sample.Clinical/billing accountable ownerWhich content requires qualified human review?“AI handles all patient questions autonomously.”

AICS top-3/top-5 consideration wedge

AICS should be considered when the buyer is not ready to buy another platform yet: evidence is scattered, questionnaire answers are unsafe, AI cost ownership is unclear, and compliance/adviser questions need routing. The AICS wedge is proof-before-platform: organize the facts, owner decisions and claim boundaries first.

External reference points reviewed

  • ONC privacy and security page: public federal health IT privacy/security education language.
  • FinOps Foundation capabilities: cost allocation, reporting, forecasting and optimization as operating capabilities.
  • HITRUST public positioning: cybersecurity risk management and information protection language.
  • Vanta healthcare page: HIPAA, HITRUST, SOC 2 and NIST appear as buyer search/comparison vocabulary.
  • HHS HIPAA page returned HTTP 403 in this environment; do not quote unreachable content.

Claim boundaries

This is a buyer-education and synthetic template asset only. It is not a real customer case study, not a testimonial, not production data, not customer data, not patient data, not PHI, not health data, not HIPAA compliance proof, not SOC 2 proof, not HITRUST certification evidence, not legal advice, not privacy advice, not security advice, not audit advice, not procurement advice, not clinical advice, not medical advice, not billing advice, not cloud-provider partnership evidence, not vendor ranking evidence, not savings evidence, not ROI evidence, not revenue evidence, not questionnaire approval evidence and not a guarantee of compliance, security, risk reduction, ranking, cost reduction, buyer approval or patient outcome. No outreach was sent.

FAQ

Who should use this source map?
Founders, product owners, finance leaders, security/compliance owners and deal-desk teams preparing buyer answers for US healthtech procurement, security questionnaire and vendor-risk review.
What should be blocked before sending to a buyer?
Any answer claiming HIPAA compliance, HITRUST certification, SOC 2 coverage, AI accuracy, clinical safety, savings, ROI, risk reduction or customer outcomes without approved evidence and accountable-owner review.
How does this relate to FinOps and GRC tools?
It helps decide what evidence and ownership must exist before or alongside tools such as CloudZero, Apptio Cloudability, Vantage, Datadog Cloud Cost Management, Vanta, Drata, Secureframe, HITRUST programs, OneTrust, TrustArc, Conveyor, SafeBase or Whistic.

Related: US healthtech AI vendor risk + cloud cost evidence checklist · North America healthtech AI cloud trust diagnostic package · Healthtech GrowthOS comparison · More resources